Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016258
Filing Date
2022-08-10
Accepted
2022-08-10 07:24:02
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgem-20220630.htm   iXBRL 10-Q 2572088
2 EX-10.1 cgem-ex10_1.htm EX-10.1 1023134
3 EX-10.2 cgem-ex10_2.htm EX-10.2 1093587
4 EX-10.3 cgem-ex10_3.htm EX-10.3 82463
5 EX-31.1 cgem-ex31_1.htm EX-31.1 17475
6 EX-31.2 cgem-ex31_2.htm EX-31.2 17224
7 EX-32.1 cgem-ex32_1.htm EX-32.1 17745
  Complete submission text file 0000950170-22-016258.txt   11581376

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cgem-20220630_cal.xml EX-101.CAL 45708
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cgem-20220630.xsd EX-101.SCH 65622
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cgem-20220630_def.xml EX-101.DEF 154590
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cgem-20220630_lab.xml EX-101.LAB 442002
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cgem-20220630_pre.xml EX-101.PRE 317393
65 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20220630_htm.xml XML 1884949
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

EIN.: 813867811 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39856 | Film No.: 221150396
SIC: 2836 Biological Products, (No Diagnostic Substances)